Ngozi Okonjo-Iweala, WTO Director-General (Salvatore Di Nolfi/Keystone via AP Images)

March 16, 2022 11:16 AM EDTUpdated 01:19 PM

A watered-down Covid-19 vaccine IP waiver nears the finish line: Will it actually expand supplies?

Zachary Brennan

Senior Editor

The US, EU, India, and South Africa have forged at least a preliminary agreement around an intellectual property (IP) waiver at the World Trade Organization …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

A watered-down Covid-19 vaccine IP waiver nears the finish line: Will it actually expand supplies?

Zachary Brennan

Senior Editor

Sign up to read this article for free.

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Vaccine biotechs say they’ve been told to stop next-gen Covid work under a Biden-era project

Recent FDA staff cuts to delay drug hearing decision by months, agency tells Vanda

Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffs

Updated: Roche’s $50B US investment includes previous build announcements

Regeneron to boost its US manufacturing through a $3B Fujifilm deal

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

A wa­tered-down Covid-19 vac­cine IP waiv­er nears the fin­ish line: Will it ac­tu­al­ly ex­pand sup­plies?

Senior Editor

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

A watered-down Covid-19 vaccine IP waiver nears the finish line: Will it actually expand supplies?